VIMPAT
As listed in the register: VIMPAT 100 mg, comprimés pelliculés
100 mg · comprimé pelliculé
- Prescription only
- Active substance
- Lacosamide
- Made by
- UCB PHARMA BELGIQUE
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Lacosamide Oral Solution). It describes the substance, not this exact product.
The precise mechanism by which Lacosamide oral solution exerts its antiepileptic effects in humans remains to be fully elucidated.
In vitro electrophysiological studies have shown that lacosamide selectively enhances slow inactivation of voltage-gated sodium channels, resulting in stabilization of hyperexcitable neuronal membranes and inhibition of repetitive neuronal firing.
Drug Interactions In Vitro Assessment of Drug Interactions In vitro metabolism studies indicate that lacosamide does not induce the enzyme activity of drug metabolizing cytochrome P450 isoforms CYP1A2, 2B6, 2C9, 2C19 and 3A4.
Metabolism and Elimination Lacosamide oral solution is primarily eliminated from the systemic circulation by renal excretion and biotransformation.
Food does not affect the rate and extent of absorption.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-09
Safety of the active substance
From the US prescribing label for the same active substance (Lacosamide Oral Solution). It describes the substance, not this exact product.
Most commonly (≥1% on lacosamide ) leading to discontinuation was dizziness.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States27 matching products
European UnionNo exact match for this strength and form
Canada15 matching products
Netherlands13 matching products
- Cosim 100 mg filmomhulde tabletten 100 mg · filmomhulde tablet
- Lacosamide Accord 100 mg 100 mg · filmomhulde tablet
- Lacosamide Amarox 100mg filmomhulde tabletten 100mg · filmomhulde tablet
- Lacosamide Aristo 100 mg 100 mg · filmomhulde tablet
- Lacosamide Glenmark 100 mg filmomhulde tabletten 100 mg · filmomhulde tablet
- Lacosamide Grindeks 100 mg filmomhulde tabletten 100 mg · filmomhulde tablet
- Lacosamide Huahai 100 mg filmomhulde tabletten 100 mg · filmomhulde tablet
- Lacosamide Neuraxpharm 100 mg filmomhulde tabletten 100 mg · filmomhulde tablet
Details
| Made by | UCB PHARMA BELGIQUE |
|---|---|
| Active substance | Lacosamide |
| Strength | 100 mg |
| Form | comprimé pelliculé |
| Route | orale |
| Dispensing (as stated by the register) | liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/08/470 |
| Name in the register | VIMPAT 100 mg, comprimés pelliculés |
| Packs | 56 plaquette(s) thermoformée(s) PVC PVDC aluminium de 1 comprimé(s) · plaquette(s) thermoformée(s) PVC PVDC aluminium de 56 comprimé(s) |
| CIS | 64357958 |
| CIP13 | 3400922473482 |
| CIP13 | 3400938829921 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
6 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.